Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -23.78%20.37M | 1.25%20.55M | -1.11%19.25M | 25.35%87.99M | 20.16%21.5M | 52.46%26.73M | 13.19%20.29M | 15.60%19.47M | -43.68%70.19M | -24.64%17.89M |
| Cost of revenue | -28.91%15.07M | 4.37%16.68M | -6.28%14.21M | 27.11%68.83M | 21.10%16.48M | 60.27%21.19M | 11.99%15.99M | 16.34%15.17M | -48.38%54.15M | -26.51%13.61M |
| Gross profit | -4.17%5.31M | -10.31%3.86M | 17.09%5.04M | 19.41%19.16M | 17.17%5.02M | 28.51%5.54M | 17.84%4.31M | 13.06%4.3M | -18.70%16.05M | -18.01%4.28M |
| Operating expense | 11.63%4.52M | -8.68%3.16M | 22.02%4.23M | 17.38%14.78M | 20.88%3.64M | 24.26%4.05M | 20.22%3.46M | 20.86%3.47M | 96.65%12.59M | 7.50%3.01M |
| Selling and administrative expenses | 11.63%4.52M | -8.68%3.16M | 22.02%4.23M | 17.38%14.78M | 16.09%3.77M | 24.26%4.05M | 20.22%3.46M | 11.15%3.47M | -3.01%12.59M | -17.70%3.25M |
| -General and administrative expense | 11.63%4.52M | -8.68%3.16M | 22.02%4.23M | 17.38%14.78M | 16.09%3.77M | 24.26%4.05M | 20.22%3.46M | 11.15%3.47M | -3.01%12.59M | -17.70%3.25M |
| Total other operating income | ---- | ---- | -33.02%142K | -40.94%616K | -45.92%126K | ---- | ---- | -15.54%212K | -84.15%1.04M | -79.58%233K |
| Operating profit | -47.27%783K | -16.90%708K | -3.49%803K | 26.85%4.38M | 8.35%1.38M | 41.70%1.49M | 9.09%852K | -10.92%832K | -74.11%3.45M | -47.55%1.27M |
| Net non-operating interest income (expenses) | 23.77%-664K | 24.63%-670K | -10.39%-712K | -35.16%-3.22M | -37.37%-805K | -45.65%-871K | -49.41%-889K | -9.51%-645K | -7.40%-2.38M | -6.57%-586K |
| Non-operating interest income | ---- | ---- | ---- | -22.35%12.32K | ---- | ---- | ---- | ---- | -67.60%15.86K | ---- |
| Non-operating interest expense | -23.77%664K | -24.63%670K | 10.39%712K | 34.78%3.23M | 37.37%805K | 45.65%871K | 49.41%889K | 9.51%645K | 5.78%2.39M | -2.14%586K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 6.83%172K | -26.59%127K | -72.82%56K | -65.20%510.28K | -103.80%-38K | -26.15%161K | -22.42%173K | 758.33%206K | 142.51%1.47M | 212.25%1M |
| Special income (charges) | 58.82%-7K | 0.00%-10K | 244.44%13K | -145.73%-15K | -44.74%21K | 10.53%-17K | 28.57%-10K | -400.00%-9K | 320.14%32.8K | 51.39%38K |
| Less:Write off | -58.82%7K | 0.00%10K | -244.44%-13K | 145.73%15K | 44.74%-21K | -10.53%17K | -28.57%10K | 400.00%9K | -320.14%-32.8K | -51.39%-38K |
| Other non-operating income (expenses) | -6.82%123K | -19.18%118K | -33.02%142K | -38.45%642.21K | -46.77%132K | -38.66%146K | 212K | 1.04M | ||
| Income before tax | -54.27%407K | 0.37%273K | -49.33%302K | -36.35%2.3M | -67.89%553K | -0.78%890K | -57.03%272K | 60.22%596K | -69.12%3.62M | -22.27%1.72M |
| Income tax | -290.91%-63K | 21.82%67K | -24.04%139K | -41.63%669.57K | -39.76%400K | -82.45%33K | -71.20%55K | 157.75%183K | -6.91%1.15M | 241.37%664K |
| Net income | -45.16%470K | -5.07%206K | -60.53%163K | -33.90%1.63M | -85.54%153K | 20.87%857K | -50.90%217K | 37.21%413K | -76.43%2.47M | -60.59%1.06M |
| Net income continuous operations | -45.16%470K | -5.07%206K | -60.53%163K | -33.90%1.63M | -85.54%153K | 20.87%857K | -50.90%217K | 37.21%413K | -76.43%2.47M | -60.59%1.06M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | -45.16%470K | -5.07%206K | -60.53%163K | -33.90%1.63M | -85.54%153K | 20.87%857K | -50.90%217K | 37.21%413K | -76.43%2.47M | -60.59%1.06M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -45.16%470K | -5.07%206K | -60.53%163K | -33.90%1.63M | -85.54%153K | 20.87%857K | -50.90%217K | 37.21%413K | -76.43%2.47M | -60.59%1.06M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -46.15%0.0028 | -7.69%0.0012 | -60.00%0.001 | -34.23%0.0098 | -85.94%0.0009 | 20.93%0.0052 | -51.85%0.0013 | 38.89%0.0025 | -76.39%0.0149 | -60.49%0.0064 |
| Diluted earnings per share | -46.15%0.0028 | -7.69%0.0012 | -60.00%0.001 | -34.23%0.0098 | -85.94%0.0009 | 20.93%0.0052 | -51.85%0.0013 | 38.89%0.0025 | -76.39%0.0149 | -60.49%0.0064 |
| Dividend per share | 0 | 0 | 0 | -46.15%0.0035 | 0.00%0.0035 | 0 | 0 | 0 | -38.10%0.0065 | -53.33%0.0035 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.